TY - JOUR
T1 - Tissue reservoirs of antiviral T cell immunity in persistent human CMV infection
AU - Gordon, Claire L.
AU - Miron, Michelle
AU - Thome, Joseph J.C.
AU - Matsuoka, Nobuhide
AU - Weiner, Joshua
AU - Rak, Michael A.
AU - Igarashi, Suzu
AU - Granot, Tomer
AU - Lerner, Harvey
AU - Goodrum, Felicia
AU - Farber, Donna L.
N1 - Funding Information:
We wish to gratefully acknowledge the generosity of the donor families and the outstanding efforts of the LiveOnNY transplant coordinators and staff for making this study possible. We also wish to thank Heather M. Lee and Brahma Kumar for assistance with tissue processing. We acknowledge the NIH Tetramer Core Facility (contract HHSN272201300006C) for provision of MHC A*6801 tetramer. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. This work was supported by National Institutes of Health grants P01AI06697 (D.L. Farber) and F31 AG047003 (J.J.C. Thome) and by the National Center for Advancing Translational Sciences (INH) grant UL1 TR000040, awarded to C.L. Gordon. C.L. Gordon was also supported by a Hutchins Family Fellowship, Fulbright Postgraduate Scholarship, and American Australian Association Fellowship. These studies were performed in the CCTI Flow Cytometry Core funded in part through an S10 Shared Instrumentation grant, 1S10RR027050.
Publisher Copyright:
© 2017 Gordon et al.
PY - 2017/1/27
Y1 - 2017/1/27
N2 - T cell responses to viruses are initiated and maintained in tissue sites; however, knowledge of human antiviral T cells is largely derived from blood. Cytomegalovirus (CMV) persists in most humans, requires T cell immunity to control, yet tissue immune responses remain undefined. Here, we investigated human CMV-specific T cells, virus persistence and CMV-associated T cell homeostasis in blood, lymphoid, mucosal and secretory tissues of 44 CMV seropositive and 28 seronegative donors. CMVspecific T cells were maintained in distinct distribution patterns, highest in blood, bone marrow (BM), or lymph nodes (LN), with the frequency and function in blood distinct from tissues. CMV genomes were detected predominantly in lung and also in spleen, BM, blood and LN. High frequencies of activated CMV-specific T cells were found in blood and BM samples with low virus detection, whereas in lung, CMV-specific T cells were present along with detectable virus. In LNs, CMV-specific T cells exhibited quiescent phenotypes independent of virus. Overall, T cell differentiation was enhanced in sites of viral persistence with age. Together, our results suggest tissue T cell reservoirs for CMV control shaped by both viral and tissue-intrinsic factors, with global effects on homeostasis of tissue T cells over the lifespan.
AB - T cell responses to viruses are initiated and maintained in tissue sites; however, knowledge of human antiviral T cells is largely derived from blood. Cytomegalovirus (CMV) persists in most humans, requires T cell immunity to control, yet tissue immune responses remain undefined. Here, we investigated human CMV-specific T cells, virus persistence and CMV-associated T cell homeostasis in blood, lymphoid, mucosal and secretory tissues of 44 CMV seropositive and 28 seronegative donors. CMVspecific T cells were maintained in distinct distribution patterns, highest in blood, bone marrow (BM), or lymph nodes (LN), with the frequency and function in blood distinct from tissues. CMV genomes were detected predominantly in lung and also in spleen, BM, blood and LN. High frequencies of activated CMV-specific T cells were found in blood and BM samples with low virus detection, whereas in lung, CMV-specific T cells were present along with detectable virus. In LNs, CMV-specific T cells exhibited quiescent phenotypes independent of virus. Overall, T cell differentiation was enhanced in sites of viral persistence with age. Together, our results suggest tissue T cell reservoirs for CMV control shaped by both viral and tissue-intrinsic factors, with global effects on homeostasis of tissue T cells over the lifespan.
UR - http://www.scopus.com/inward/record.url?scp=85019264785&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85019264785&partnerID=8YFLogxK
U2 - 10.1084/jem.20160758
DO - 10.1084/jem.20160758
M3 - Article
C2 - 28130404
AN - SCOPUS:85019264785
VL - 214
SP - 651
EP - 667
JO - Journal of Experimental Medicine
JF - Journal of Experimental Medicine
SN - 0022-1007
IS - 3
ER -